Medical Devices Indonesia

Indonesia Molecular Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Indonesia Molecular Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Technology, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Indonesia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $145.8 Mn Placeholder estimate
Estimate 2025 $162.1 Mn 0.5% of the global market
Projected 2034 $421.5 Mn 160% Adds $259.3 Mn over 9 forecast years
CAGR 2025–2034 11.2% Faster than 84% of 19 Medical Devices markets here
Key players 6 +1
  • Indonesia is 0.54% of the global market.
  • In APAC, the largest is China at $2.70 Bn.
  • Fastest growing: India at 12.7% a year.
  • Indonesia ranks 7th of 14 by size in APAC.

Market size projection

Indonesia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$259.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Molecular Diagnostics Market market size by year, Indonesia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $145.8 Mn — —
2025 (base) $162.1 Mn +$16.3 Mn —
2026 (forecast) $180.3 Mn +$18.2 Mn +11.2%
2027 (forecast) $200.5 Mn +$20.2 Mn +23.7%
2028 (forecast) $222.9 Mn +$22.5 Mn +37.5%
2029 (forecast) $247.9 Mn +$25.0 Mn +52.9%
2030 (forecast) $275.6 Mn +$27.8 Mn +70%
2031 (forecast) $306.5 Mn +$30.9 Mn +89.1%
2032 (forecast) $340.8 Mn +$34.3 Mn +110.2%
2033 (forecast) $379.0 Mn +$38.2 Mn +133.8%
2034 (forecast) $421.5 Mn +$42.4 Mn +160%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Indonesia Molecular Diagnostics Market Analysis at a glance
Market size, 2025$162.1 Mn placeholder estimate
Forecast, 2034$421.5 Mn placeholder estimate
Growth (CAGR), 2025–203411.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTechnology, application and end user (see all)
Key playersRoche, Abbott Laboratories, Thermo Fisher Scientific Inc., Qiagen N.V., Hologic, Inc. and 1 more (see all)
Regulator in IndonesiaMinistry of HealthSource: Ministry of Health of Indonesia. Checked 19 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Indonesia Molecular Diagnostics Market Analysis Executive Summary

Molecular diagnostics tests read DNA, RNA and proteins to find infections, cancer and inherited disease.

Key segments of the molecular diagnostics market include technology (PCR, Sequencing and Isothermal Amplification) and application (Infectious Disease, Oncology and Genetic Disease).

Bar chart: Indonesia Molecular Diagnostics market size, 2024–2034, placeholder estimates. $145.8 Mn in 2024, $162.1 Mn in 2025 and $421.5 Mn in 2034, 11.2% CAGR.
Indonesia Molecular Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Indonesia Molecular Diagnostics Market Dynamics

Market Growth Drivers

Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the molecular diagnostics market.

Opportunity

Automation, smaller and cheaper instruments and growth in cancer and genetic testing give the molecular diagnostics market room to grow.

Market Restraints

Costly instruments, a shortage of skilled lab staff and uneven payment for new tests hold back the molecular diagnostics market.

Competitive Landscape for Molecular Diagnostics Market in Indonesia

The molecular diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Molecular Diagnostics Market in Indonesia

Molecular Diagnostics in Indonesia: rules and payment

Medical devices need a marketing authorisation from the Ministry of Health before sale.⁠[1] The national health insurance scheme (JKN), run by BPJS Kesehatan, covers most of the population.⁠[2]

[1] Ministry of Health of Indonesia. Checked 19 Nov 2026.

[2] BPJS Kesehatan. Checked 19 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how molecular diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Indonesia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Molecular Diagnostics right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Molecular Diagnostics in context

Indonesia compared

  • Health spending per person: 132 US$ per person (2023). World: 1,317 US$ per person (2023). 11th highest of the 17 countries we cover in APAC.[1]
  • Doctors: 0.52 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 16th highest of the 17 countries we cover in APAC.[2]
  • People aged 65 and over: 7.5% of people (2025). World: 10.4% of people (2025). 11th highest of the 18 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Molecular Diagnostics market in Indonesia?
Placeholder estimate: about $162.1 Mn in 2025, rising to about $421.5 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Molecular Diagnostics market in Indonesia growing?
Placeholder estimate: about 11.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Molecular Diagnostics market report cover?
The report splits the market by technology (PCR, Sequencing, Isothermal Amplification, Microarrays and more), application (Infectious Disease, Oncology, Genetic Disease, Blood Screening) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Molecular Diagnostics market?
Key players include Roche, Abbott Laboratories, Thermo Fisher Scientific Inc., Qiagen N.V., Hologic, Inc. and Danaher Corporation.
What is driving the Molecular Diagnostics market?
Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the molecular diagnostics market.
Who regulates Molecular Diagnostics in Indonesia?
Medical devices need a marketing authorisation from the Ministry of Health before sale. Source: Ministry of Health of Indonesia. Checked 19 Nov 2026.
How is healthcare paid for in Indonesia?
The national health insurance scheme (JKN), run by BPJS Kesehatan, covers most of the population. Source: BPJS Kesehatan. Checked 19 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Indonesia

See all

Related on diagnostics and lab testing and genomics

See the topic